An object of the present invention is to provide an emulsification-stable pesticidal composition having ant-control, rotcontrol and mildew-control effects. Another object of the present invention is to provide a composition having pesticidal effects, and particularly antimicrobial effects, for protecting industrial materials such as wood, pulp, paper, fibers, adhesives, films subject to deterioration (rotting) and contamination by insects and particularly by microorganisms. A pesticidal composition is used that comprises an emulsification stabilizer selected from the group consisting of lactic acid, glycolic acid, citric acid, succinic acid, benzoic acid and a mixture thereof, a fungicide like 2-(thiazol-4ine)benzimidazole; a further triazole-based fungicide component, a pyrethroid insecticide component or a (thia) nicotinyl insecticide or another insecticide component, a mixed solvent comprising a glycol-based solvent and methyl pyrrolidone, and a surfactant.

Syngenta Crop Protection, Inc.

Emulsifications-stable pesticidal composition

The present invention addresses the problem of providing an inhibitor for retinochoroidal disorders, in particular, an inhibitor for retinochoroidal scar formation and retinochoroidal atrophy in an epiretinal, intraretinal or subretinal tissue. This problem can be solved by preparing an inhibitor for retinochoroidal disorders which comprises, as an active ingredient, (E)-4-(2-{3-[(1H-pyrazol-1-yl)methyl]-5,5,8,8-tetramethyl-5,6,7,8-tetrahy- dronaphthalene-2-yl}vinyl)benzoic acid, an ester thereof or a salt of the same. The inhibitor for retinochoroidal disorders can inhibit collagen atrophy of retinal pigment epithelium cells, fibroblasts, glial cells and the like and thus inhibit retinochoroidal disorders.

Yamaguchi University

YAMAGUCHI UNIVERSITY

Inhibitor for retinochoroidal disorders

Diseases Mediated by transglutaminase, such as Huntington's Disease, spinobulbar atrophy, spinocerebellar ataxia, and dentatorubralpallidoluysian atrophy, as well as inflammatory diseases of the central nervous system, including mautiple sclerosis, rheumatoid arthritis, and insulin dependent diabetes mellitus, can be treated by administering a transglutaminase inhibitor such as monadansyl cadaverine, monoamines and diamines such as cystamine, putrescine, GABA. (gamma-amino benzoic acid), N-benzyloxy carbonyl, 5-deazp-4-oxonorvaline p-nitrophenylester, glycine methyl ester, CuSO4, and the oral anti-hyperglycemic agent tolbutamide.

benzoic/atrofia

Emulsifications-stable pesticidal composition

Inhibitor for retinochoroidal disorders

Method and compositions for treating diseases mediated by transglutaminase activity

Il database di erbe medicinali più completo supportato dalla scienza